Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Senseonics is a medical technology company and creator of the Eversense continuous glucose monitoring (CGM) system—the first and only long-term implantable CGM. Its Eversense system uses implantable sensors with wear durations up to 365 days (with a next-generation option up to 180 days) for diabetes management. The company also lists patents, leadership, investor relations, and regulatory filings, indicating a focus on research, development, and corporate governance around its CGM technology.
Parse Score
Sources
globalgrowthinsights.com shapes more of what AI says about Senseonics than any other source, at 100% of its citations.